Carmichael Hill & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.37K | Hold |
18
| – | – | ﹤0.01% | 506 |
|
|
2024
Q2 | $8.44K | Hold |
18
| – | – | ﹤0.01% | 490 |
|
|
2024
Q1 | $7.53K | Hold |
18
| – | – | ﹤0.01% | 511 |
|
|
2023
Q4 | $7.33K | Hold |
18
| – | – | ﹤0.01% | 509 |
|
|
2023
Q3 | $6.26K | Hold |
18
| – | – | ﹤0.01% | 516 |
|
|
2023
Q2 | $6.34K | Hold |
18
| – | – | ﹤0.01% | 522 |
|
|
2023
Q1 | $5.67K | Hold |
18
| – | – | ﹤0.01% | 532 |
|
|
2022
Q4 | $5.2K | Hold |
18
| – | – | ﹤0.01% | 514 |
|
|
2022
Q3 | $5K | Hold |
18
| – | – | ﹤0.01% | 561 |
|
|
2022
Q2 | $5K | Hold |
18
| – | – | ﹤0.01% | 558 |
|
|
2022
Q1 | $5K | Hold |
18
| – | – | ﹤0.01% | 576 |
|
|
2021
Q4 | $4K | Hold |
18
| – | – | ﹤0.01% | 609 |
|
|
2021
Q3 | $3K | Hold |
18
| – | – | ﹤0.01% | 619 |
|
|
2021
Q2 | $4K | Hold |
18
| – | – | ﹤0.01% | 585 |
|
|
2021
Q1 | $4K | Hold |
18
| – | – | ﹤0.01% | 578 |
|
|
2020
Q4 | $4K | Buy |
+18
| New | +$4K | ﹤0.01% | 562 |
|